Nov 30
|
Johnson & Johnson (NYSE:JNJ) is largely controlled by institutional shareholders who own 71% of the company
|
Nov 30
|
J&J Hired Thousands of Data Scientists. Will The Strategy Pay Off?
|
Nov 29
|
20 Countries With The Lowest Retirement Ages in The World
|
Nov 29
|
Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
|
Nov 29
|
15 States with the Best Economy Right Now
|
Nov 29
|
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
|
Nov 29
|
3 medtech spinoffs that reshaped the industry in 2023, and what to expect next
|
Nov 28
|
AWS expands big pharma partnerships in manufacturing, AI, and R&D
|
Nov 28
|
2 Unstoppable Dividend Stocks Trading Near 52-Week Lows to Buy Now
|
Nov 27
|
Roku upgraded, Lucid Group downgraded: Wall Street's top analyst calls
|
Nov 27
|
5 Stocks You Can Confidently Invest $500 In Right Now
|
Nov 26
|
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
|
Nov 8
|
15 Best American Dividend Stocks To Buy Now
|
Nov 8
|
Pharma ETFs in Focus Post Q3 Earnings
|
Nov 8
|
3 Brilliant Artificial Intelligence Stocks to Buy and Hold Forever
|
Nov 8
|
'Things were way tougher': Charlie Munger shares blunt message with whiners worried about 'hardship' — plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances
|
Nov 7
|
J&J targets 2024 for Ottava FDA filing
|
Nov 7
|
2 Magnificent Dividend Stocks Trading Near 52-Week Lows to Buy Now and Hold at Least a Decade
|
Nov 6
|
Controversial brand back, survives Chapter 11 bankruptcy
|
Nov 6
|
J&J links radiofrequency catheter to improved quality of life in atrial fibrillation study
|